Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07377006 · ClinicalTrials.gov registry record · NA
Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
A NA study, sponsored by M.D. Anderson Cancer Center.
- Not yet
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT07377006: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.
NCT07377006 is a NA study that has not yet begun recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 108 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07377006, a NA study, has not yet begun recruiting, sponsored by M.D. Anderson Cancer Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
This clinical trial identifies factors associated with completing genetic testing, aids in the development of a decision support tool, and tests how well the decision support tool works to enhance germline genetic testing in patients with prostate cancer. Germline genetic testing is a guideline-recommended standard of care for many patients with prostate cancer. Completing genetic testing can enable the use of targeted therapies, offers access to novel clinical trials, provides valuable information, and can help identify at risk family members. The decision support tool may educate patients and assist in the decision to engage with germline genetic testing.
Interventions
- PROCEDURE Biospecimen Collection
- BEHAVIORAL Behavioral Intervention
- OTHER Electronic Health Record Review
- OTHER Genetic Testing
- OTHER Genetic Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07377006
The ClinicalTrials.gov registry entry for NCT07377006 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Biospecimen Collection is the first listed.
NCT07377006 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07377006 about?
NCT07377006 is a clinical study titled "Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer". This clinical trial identifies factors associated with completing genetic testing, aids in the development of a decision support tool, and tests how well the decision support tool works to enhance germline genetic testing in patients with prostate cancer. Germline genetic testing is a guideline-reco...
What is the current status of trial NCT07377006?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2026-10-01. Estimated completion is 2030-12-31.
What interventions are being tested in trial NCT07377006?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Behavioral Intervention (BEHAVIORAL), Electronic Health Record Review (OTHER), Genetic Testing (OTHER), Genetic Counseling (OTHER).
Who is sponsoring clinical trial NCT07377006?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.